News | August 04, 2010

Pencil Beam Technology May be the Future of Radiation Therapy

August 5, 2010 — New tools are enabling physicians at the Proton Therapy Center at The University of Texas MD Anderson Cancer to harness supercharged proton particles and conform them more precisely to the rugged landscape and uneven contours of a tumor. Using a technology known as pencil beam scanning or spot scanning, protons are given the mission to hone in on cancer cells and destroy them.

As much an art form as a war tactic, pencil beam proton therapy has the ability to treat the most complex of tumors, like those of the prostate, brain, base of the skull and eye, while leaving healthy tissue and critical structures virtually untouched. This is achieved by using proton particles, accelerated to nearly the speed of light, to mimic the shape of a tumor and effectively deposit their energy within the confines of it with sub-millimeter precision.

In nearly a decade since pencil beam's birth in a Swiss physics institute, the practitioners in radiation science at MD Anderson's Proton Therapy Center have integrated the tested technology into the institution's multidisciplinary approach to patient care and translational cancer research.

A New Frontier for Proton Therapy

Most proton patients are treated with a technique known as passive scattering, which uses apertures to shape the proton beam and deliver a uniform dose to the tumor. Since opening in the spring of 2006, MD Anderson's Proton Therapy Center has treated nearly 1,700 patients with this passive scattering technique.

The technology continues to build on the patient benefits already offered with proton therapy – more targeted, higher tumor dose, shorter treatment times, reduced side effects and increased treatment options – to treat complicated tumors perilously close to critical structures, such as the eye, brain and esophagus.

"The difference between passive scattering and pencil beam is like painting something with a can of spray paint versus using an airbrush," said Andrew Lee, M.D., M.P.H., associate professor in the Department of Radiation Oncology at MD Anderson, and the director of the Proton Therapy Center. "Pencil beam is more like a very fine airbrush. Instead of needing a brass template to define the shape, the proton beam is made ultra fine to conform to the contours and landscape of a tumor. When all these small beams are combined, they can cover the entire tumor volume with a high degree of conformality. If the tumor is shaped like an egg, then the proton dose will look like an egg."

For more information: www.mdanderson.org/proton

Related Content

ASTRO and ASCO Launch New Cancer Care Quality Registry
News | Radiation Therapy | January 22, 2018
January 22, 2018 — A registry that tracks the quality of medical care provided to patients receiving cancer treatment
First Hospitals Achieve Inter-System Connectivity Across Accuray Radiation Therapy Platforms
News | Radiation Therapy | January 19, 2018
Accuray Inc. announced recently that the Heidelberg University Hospital in Heidelberg, Germany, and Oscar Lambret...
RayStation Selected for New Carbon Ion Therapy Center in Japan
News | Treatment Planning | January 18, 2018
January 18, 2018 – RayStation has been chosen as the treatment planning system for a new carbon-ion therapy facility
Raysearch Receives First Order for the Raycare Oncology Information System
News | Oncology Information Management Systems (OIMS) | January 18, 2018
January 18, 2018 – Anderson Regional Cancer Center (ARCC) in Meridian, Mississippi, has placed the first order for...
Mevion Receives 510(k) Clearance for Hyperscan Pencil Beam Scanning Proton Therapy
Technology | Proton Therapy | January 04, 2018
Mevion Medical Systems has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Mevion S250i...
Study Compares Radiosurgery and Whole-Brain Radiation in Lung Cancer Patients With Multiple Brain Metastases
News | Radiation Therapy | January 03, 2018
Although targeted therapies have produced dramatic advances in the ability to control some types of advanced lung...
MEDraysintell Downgrades Proton Therapy Market Projection for 2030
News | Proton Therapy | January 02, 2018
MEDraysintell recently downgraded its projection for proton therapy rooms expected to be operational in 2030 from 1,200...
California US Oncology Network Centers Adopt Xoft Electronic Brachytherapy System for Early-Stage Non-Melanoma Skin Cancer
News | Brachytherapy Systems | January 02, 2018
iCAD Inc. announced that its Xoft Axxent Electronic Brachytherapy (eBx) System is now available at two California-based...
Blue Phantom System Used for Acceptance of First European Varian Halcyon Machine
News | Radiation Therapy | January 02, 2018
IBA (Ion Beam Applications S.A.) announced in November the acceptance and beam model validation of the first Varian...
Study Finds Link Between Breast Cancer Treatments and Cellular Aging Markers
News | Women's Health | January 02, 2018
January 2, 2018 — A new study found women who had received chemotherapy and/or...
Overlay Init